Patent · US Active

Methods of treating pain using anti-GPR160 antibodies

US10851378B2 · kind B2 · utility

0Cited by

0References

21Claims

0Family size

Assignee

Saint Louis University · US

Inventors

Daniela Salvemini · Chesterfield, US
Gina L. C. Yosten · Chesterfield, US
Willis K. Samson · Chesterfield, US

Key dates

Filing date	Jul 15, 2016
Grant date	Dec 1, 2020
Priority date	—
Expiry date	Jul 15, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2310/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The disclosure provides methods and compositions for inhibiting pain by administering a GPR160 antagonist to a subject in need thereof. Also provided are methods of using GPR160 antagonists in combination with other pain therapies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.